HEMEO

About HEMEO

We build Clinical Support System predicting coagulation problems. Our A.I. powered technology enables earlier and personalised therapies. Our algorithms have been trained and verified against a +5,000 clinical patient database. We are currently building research collaboration with leading academic centres around the world to validate our algorithms and our coagulation model. Our company is based in The Netherlands where we benefit from a rich ecosystem with our partnerships with NLC, the European Healthtech Venture Builder, and with Philips where our core technology was originally developed.

Address

• Headquarters

  Paasheuvelweg 25-D51105BP AmsterdamNoord-Holland, Netherlands

Team by function

Based on 1 public job profiles as of 4 September 2026.

• Founder / Owner1